Literature DB >> 19569190

Temporal trends in the incidence and survival of cancers of the upper aerodigestive tract in Ontario and the United States.

Shlok Gupta1, Weidong Kong, Yingwei Peng, Qun Miao, William J Mackillop.   

Abstract

The Ontario Cancer Registry (OCR) and the Surveillance, Epidemiology and End Results (SEER) databases were used to describe temporal trends in the incidence and survival of squamous cancers of the upper aerodigestive tract (UADT) in Ontario and the US between 1984 and 2001. Between the 1984-86 and 1999-01 periods, the age-adjusted incidence rate of all first primary cancers of the UADT decreased from 11.6 (11.2-12.0) to 8.8 (8.5-9.1) in Ontario and 13.0 (12.7-13.3) to 10.2 (10.0-10.4) in the US. Significant decreases in incidence were observed in many UADT sites but there was no significant change in the incidence of cancer of the oropharynx in either the US or Canada. Over the same period, the 5-year relative survival for all UADT cancers increased from 49.2% (47.2-51.2%) to 57.1%(55.0-59.1%) in Ontario and from 48.1% (46.9-49.3%) to 52.4% (51.2-53.6%) in the US. This significant improvement in the outcome of UADT cancer was largely due to a dramatic increase in the 5-year relative survival for cancers of the oropharynx from 31.1% (27.1-35.1%) to 53.6% (49.3-57.9%) in Ontario and from 35.3% (32.9-37.8%) to 51.0% (48.7-53.3%) in the US. Smaller increases in survival were observed in cancers of the oral cavity, nasopharynx, and hypopharynx, but there was no evidence of any increase in survival for cancer of the larynx. These results are consistent with the hypothesis that there has been a major change in the etiology of cancer of the oropharynx in Canada and the US and a concomitant change in its response to therapy. (c) 2009 UICC.

Entities:  

Mesh:

Year:  2009        PMID: 19569190     DOI: 10.1002/ijc.24533

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  54 in total

1.  Does the frequency of routine follow-up after curative treatment for head-and-neck cancer affect survival?

Authors:  S F Hall; T Owen; R J Griffiths; K Brennan
Journal:  Curr Oncol       Date:  2019-10-01       Impact factor: 3.677

2.  Wnt/Beta-Catenin Signal Inhibitor HC-1 Sensitizes Oral Squamous Cell Carcinoma Cells to 5-Fluorouracil through Reduction of CD44-Positive Population.

Authors:  Satoshi Yokogi; Toshiaki Tsubota; Keita Kanki; Junya Azumi; Noriko Itaba; Hiroyuki Oka; Minoru Morimoto; Kazuo Ryoke; Goshi Shiota
Journal:  Yonago Acta Med       Date:  2016-06-29       Impact factor: 1.641

3.  Erlotinib and gefitinib responsiveness in head and neck cancer cell lines--a comparing analysis with cetuximab.

Authors:  Stefan Hartmann; Norbert Neckel; Axel Seher; Grit Mutzbauer; Roman C Brands; Christian Linz; Alexander C Kübler; Urs D A Müller-Richter
Journal:  Clin Oral Investig       Date:  2015-08-23       Impact factor: 3.573

4.  MAGE-A9 in head and neck cancer: Prognostic value and preclinical findings in the context of irradiation.

Authors:  Till J Meyer; Stefan Hartmann; Gisela Wohlleben; Muna Brisam; Axel Seher; Alexander C Kübler; Bülent Polat; Urs D A Müller-Richter
Journal:  Mol Clin Oncol       Date:  2018-01-19

5.  Nrf2 regulates cellular behaviors and Notch signaling in oral squamous cell carcinoma cells.

Authors:  Hong Fan; Chorlada Paiboonrungruan; Xinyan Zhang; Justin R Prigge; Edward E Schmidt; Zheng Sun; Xiaoxin Chen
Journal:  Biochem Biophys Res Commun       Date:  2017-08-15       Impact factor: 3.575

6.  Gene expression analyses associated with malignant phenotypes of metastatic sub-clones derived from a mouse oral squamous cell carcinoma Sq-1979 cell line.

Authors:  Mitsutaka Adachi; Masako Mizuno-Kamiya; Eiji Takayama; Harumi Kawaki; Toshihiro Inagaki; Shigeki Sumi; Masayuki Motohashi; Yasunori Muramatsu; Shin-Ichiro Sumitomo; Michio Shikimori; Yutaka Yamazaki; Nobuo Kondoh
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

7.  Apoptosis-sensitizing activity of birinapant in head and neck squamous cell carcinoma cell lines.

Authors:  Roman C Brands; Mario J J Scheurer; Stefan Hartmann; Axel Seher; Alexander C Kübler; Urs D A Müller-Richter
Journal:  Oncol Lett       Date:  2018-01-12       Impact factor: 2.967

8.  Temporal trends in the association between socioeconomic status and cancer survival in Ontario: a population-based retrospective study.

Authors:  Andrew Dabbikeh; Yingwei Peng; William J Mackillop; Christopher M Booth; Jina Zhang-Salomons
Journal:  CMAJ Open       Date:  2017-09-06

9.  Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53.

Authors:  Mayur A Gadhikar; Maria Rita Sciuto; Marcus Vinicius Ortega Alves; Curtis R Pickering; Abdullah A Osman; David M Neskey; Mei Zhao; Alison L Fitzgerald; Jeffrey N Myers; Mitchell J Frederick
Journal:  Mol Cancer Ther       Date:  2013-07-09       Impact factor: 6.261

10.  Did the addition of concomitant chemotherapy to radiotherapy improve outcomes in hypopharyngeal cancer? A population-based study.

Authors:  S F Hall; R Griffiths
Journal:  Curr Oncol       Date:  2016-08-12       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.